| pubmed-article:18022917 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18022917 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
| pubmed-article:18022917 | lifeskim:mentions | umls-concept:C0151546 | lld:lifeskim |
| pubmed-article:18022917 | lifeskim:mentions | umls-concept:C0085405 | lld:lifeskim |
| pubmed-article:18022917 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18022917 | pubmed:dateCreated | 2007-12-24 | lld:pubmed |
| pubmed-article:18022917 | pubmed:abstractText | Relapse of tumors in patients with oral cavity squamous cell carcinoma (OSCC) is associated with a poor prognosis. In addition, salvage therapy may be a significant source of morbidity in patients with relapsing OSCC. The objective of the current study was to determine prognostic factors that predict which patients may benefit from such treatment. | lld:pubmed |
| pubmed-article:18022917 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18022917 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18022917 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18022917 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18022917 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:18022917 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:HsuehChuenC | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:YenTzu-ChenTC | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:ChengAnn-JoyA... | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:NgShu-HangSH | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:LinChih-HungC... | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:WangHung-Ming... | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:ChenI-HowIH | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:LiaoChun-TaCT | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:ChangJoseph... | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:HuangShiang-F... | lld:pubmed |
| pubmed-article:18022917 | pubmed:author | pubmed-author:LeeLi-YuLY | lld:pubmed |
| pubmed-article:18022917 | pubmed:copyrightInfo | 2007 American Cancer Society | lld:pubmed |
| pubmed-article:18022917 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18022917 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:18022917 | pubmed:volume | 112 | lld:pubmed |
| pubmed-article:18022917 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18022917 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18022917 | pubmed:pagination | 94-103 | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:meshHeading | pubmed-meshheading:18022917... | lld:pubmed |
| pubmed-article:18022917 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18022917 | pubmed:articleTitle | Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when? | lld:pubmed |
| pubmed-article:18022917 | pubmed:affiliation | Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan. | lld:pubmed |
| pubmed-article:18022917 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18022917 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18022917 | lld:pubmed |
